GMP, the grey-market premium, is fueling India’s IPO chatter. Before listing, hype rides high around Lenskart; after listing, the shine often fades into reality.
Two posts crystallize the pattern: GMP Before Listing- Hype. GMP After Listing- Reality. The story repeats with Groww, where listing buzz gives way to a reality check that investors aren’t shy about calling out. [1]
On the ground, retail holders ride the swing. A commenter asked about averaging around ₹130 for Groww and framed it as a long-term hold, underscoring how hype can pull in casual investors even as the core story remains unsettled. [2]
Bloomberg captures the mood around Lenskart’s debut, noting a 72.8‑billion rupees IPO that has sparked social-media chatter over startup valuations. Analysts flag high expectations, yet the listing day can wrinkle those bets as valuations fight with fundamentals. [3]
All this points to a pattern: social chatter can draw in retail money, but listing-day dynamics and real-world valuations ultimately steer outcomes. The key for now is watching GMP trends and how hype translates into actual performance on the first trading day.
References
GMP Before Listing- Hype. GMP After Listing- Reality.
Describes pre-listing hype and pre-listing GMP surges, post-listing crashes; cites Lenskart, Groww; critiques social-media driven IPO culture in India today.
View sourceGMP Hype vs Reality
GMP hype around Indian IPOs (Lenskart, Groww) questioned; asks plans and averaging on listing, hints at long-term stance
View sourceAll Eyes on India's Booming IPO Market as Investors Focus on Lenskart Listing
Indian markets expect gains from IPOs like Lenskart; analysts note paint sector strength and uneven banking signals; valuations stretched.
View source